Summary & Overview
HCPCS C9735: Anoscopy with Directed Submucosal Injection(s)
HCPCS Level II code C9735 denotes an anoscopy procedure performed with directed submucosal injection(s) of any substance. The code captures a combined diagnostic and therapeutic anoscopic intervention used to visualize the anal canal and deliver targeted injections beneath the mucosa. Nationally, this code matters for accurate tracking of anorectal procedural utilization, appropriate billing for combined visualization and injection services, and for payers to distinguish this bundled service from separate anoscopy or injection-only services.
Key payers reviewed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for anoscopy with submucosal injection, common sites of service, payer coverage considerations, and benchmarks where available. The publication provides clarity on coding intent, common billing scenarios, and related code groupings to aid billing teams, compliance staff, and clinical leaders in aligning documentation with the code description.
This summary offers practical reference information on what C9735 represents, why correct coding matters for reimbursement and utilization measurement, and what elements of documentation typically support use of the code. Data not provided in the source material (for example, specific modifiers, fee benchmarks, or associated taxonomies) are noted as unavailable.
Billing Code Overview
HCPCS Level II code C9735 describes an anoscopy procedure with directed submucosal injection(s) of any substance. This service involves visualization of the anal canal and distal rectum using an anoscope, combined with targeted submucosal injection beneath the mucosal surface.
-
Service type: Procedural diagnostic and therapeutic anoscopy with directed submucosal injection(s).
-
Typical site of service: Ambulatory surgical center, hospital outpatient department, or clinic-based procedural suite where anoscopy and minor anorectal procedures are performed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient presents to a colorectal clinic with persistent rectal bleeding and symptomatic internal hemorrhoids refractory to conservative measures. After examination and anoscopy confirms targeted internal hemorrhoidal tissue and visible submucosal vessels, the colorectal surgeon performs an anoscopy with directed submucosal injection of a sclerosing agent into the submucosal plane to induce fibrosis and reduce hemorrhoidal engorgement. The clinical workflow includes pre-procedure consent and review of anticoagulation, positioning in the left lateral decubitus or prone jackknife position, application of topical or local anesthesia as indicated, insertion of an anoscope for visualization, targeted submucosal injections under direct vision, hemostasis assessment, brief post-procedure monitoring for bleeding or vasovagal response, discharge with post-procedure instructions, and documentation of indication, technique, agent, volume injected, number and location of injection sites, and any immediate complications.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when a distinct E/M visit is performed and documented on the same day as C9735 unrelated to the injection itself |